drugset / Trial / NCT07093970
A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to assess the safety, efficacy, pharmacokinetics, and immunogenicity of MRG006A in patients with advanced solid tumors.
Timeline
- Start
- 2024-07-24
- Primary completion
- 2027-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MRG006A | Unknown | — | Intravenous |